Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized treatment approach to gastroenteropancreatic neuroendocrine tumors: a medical oncologist's perspective.

European journal of gastroenterology & hepatology - 1 Sept 2016

Paul Davinder, Ostwal Vikas, Bose Subhadeep, Basu Sandip, Gupta Sudeep

Abstract excerpt

The medical management of gastroenteropancreatic neuroendocrine tumors involves treatment of symptomatic disease related to hormone secretions or bulky unresectable metastatic disease. Combining gallium DOTA with fluorine-18 fluorodeoxyglucose-PET along with histopathological grading helps to determine tumor heterogeneity and seek reasons for poor response to therapy. In the light of adding chemotherapy in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Neuroendocrine
Share to Diagnostic Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Neoplasms

Share to Medical Oncology

Share to Molecular Diagnostic Techniques

Share to Molecular Targeted Therapy

Share to Neoplasm Grading

Share to Patient Selection

Source

Identifiers

PMID: 27257869
DOI: 10.1097/MEG.0000000000000674

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized treatment approach to gastroenteropancreatic neuroendocrine tumors: a medical oncologist's perspective.PMID 27257869Read ↗

[Classification and clinicopathological characteristics of gastroenteropancreatic neuroendocrine neoplasms].Semantic proximity Read ↗

Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.Semantic proximity Read ↗

Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needsSemantic proximity Read ↗

The diversity and commonalities of gastroenteropancreatic neuroendocrine tumorsSemantic proximity Read ↗

The evolving landscape of neuroendocrine tumors.Semantic proximity Read ↗

Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances.Semantic proximity Read ↗

Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and modelsSemantic proximity Read ↗

Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasmsSemantic proximity Read ↗

Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysisSemantic proximity Read ↗

The molecular genetics of gastroenteropancreatic neuroendocrine tumorsSemantic proximity Read ↗

Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implicationsSemantic proximity Read ↗

New Model for Gastroenteropancreatic Large-Cell Neuroendocrine Carcinoma: Establishment of Two Clinically Relevant Cell LinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.